https://medicaex.com/businesswire/babylon-announces-additional-details-on-its-upcoming-1-for-25-reverse-share-split-2/ 2022-12-08T22:12:09+00:00 https://medicaex.com/businesswire/community-invited-to-ribbon-cutting-ceremony-for-farmworker-equity-express-bus-mobile-resource-center/ 2022-12-08T22:12:07+00:00 https://medicaex.com/businesswire/labcorp-opens-new-los-angeles-based-laboratory/ 2022-12-08T22:12:07+00:00 https://medicaex.com/businesswire/bristol-myers-squibb-announces-dividend-increase/ 2022-12-08T22:12:07+00:00 https://medicaex.com/businesswire/babylon-announces-additional-details-on-its-upcoming-1-for-25-reverse-share-split/ 2022-12-08T22:12:05+00:00 https://medicaex.com/businesswire/taiwan-excellence-the-oscars-of-taiwan-industries-unveils-2023-taiwan-excellence-award-winners/ 2022-12-08T22:12:05+00:00 https://medicaex.com/businesswire/exelixis-provides-update-on-phase-3-contact-01-trial-evaluating-cabozantinib-in-combination-with-atezolizumab-in-patients-with-metastatic-non-small-cell-lung-cancer-previously-treated-with-immunothe-2/ 2022-12-08T21:12:09+00:00 https://medicaex.com/businesswire/ipsen-provides-update-on-phase-iii-contact-01-trial-evaluating-cabozantinib-in-combination-with-atezolizumab-in-patients-with-metastatic-non-small-cell-lung-cancer-previously-treated-with-immunother-2/ 2022-12-08T21:12:09+00:00 https://medicaex.com/businesswire/lululemon-athletica-inc-announces-third-quarter-fiscal-2022-results/ 2022-12-08T21:12:08+00:00 https://medicaex.com/businesswire/guardant-health-announces-collaboration-with-astrazeneca-to-develop-companion-diagnostic-to-identify-patients-with-esr1-mutated-metastatic-breast-cancer/ 2022-12-08T21:12:05+00:00 https://medicaex.com/businesswire/ipsen-provides-update-on-phase-iii-contact-01-trial-evaluating-cabozantinib-in-combination-with-atezolizumab-in-patients-with-metastatic-non-small-cell-lung-cancer-previously-treated-with-immunotherap/ 2022-12-08T21:12:05+00:00 https://medicaex.com/businesswire/zoetis-declares-first-quarter-2023-dividend-board-approves-15-payment-increase/ 2022-12-08T21:12:05+00:00 https://medicaex.com/businesswire/alnylam-submits-supplemental-new-drug-application-snda-to-u-s-food-and-drug-administration-fda-for-onpattro-patisiran-for-the-treatment-of-the-cardiomyopathy-of-attr-amyloidosis/ 2022-12-08T21:12:05+00:00 https://medicaex.com/businesswire/exelixis-provides-update-on-phase-3-contact-01-trial-evaluating-cabozantinib-in-combination-with-atezolizumab-in-patients-with-metastatic-non-small-cell-lung-cancer-previously-treated-with-immunothera/ 2022-12-08T21:12:04+00:00 https://medicaex.com/businesswire/midocean-partners-exits-nutrabolt-investment/ 2022-12-08T20:12:07+00:00 https://medicaex.com/businesswire/gale-healthcare-solutions-names-tulsi-dharmarajan-chief-product-officer/ 2022-12-08T20:12:06+00:00 https://medicaex.com/businesswire/medical-gloves-global-market-report-2022-growing-number-of-surgeries-fuels-sector-researchandmarkets-com/ 2022-12-08T19:12:04+00:00 https://medicaex.com/businesswire/healthcare-adhesive-tapes-global-market-report-2022-featuring-3m-cardinal-health-nitto-denko-johnson-johnson-paul-hartmann-researchandmarkets-com/ 2022-12-08T19:12:04+00:00 https://medicaex.com/businesswire/global-gastrointestinal-partnering-report-and-directory-2015-2022-deal-trends-players-and-financials-analysis-for-500-agreements-researchandmarkets-com/ 2022-12-08T19:12:03+00:00 https://medicaex.com/businesswire/sonde-health-raises-19-25-million-series-b-to-build-the-next-generation-of-voice-based-health-monitoring-4/ 2022-12-08T18:12:11+00:00 https://medicaex.com/businesswire/global-monoclonal-antibodies-market-to-reach-299-9-billion-by-2027-at-a-cagr-of-6-2-researchandmarkets-com/ 2022-12-08T18:12:11+00:00 https://medicaex.com/businesswire/global-distribution-partnering-terms-and-agreements-in-pharma-biotech-and-diagnostics-2015-2022-an-understanding-and-analysis-of-how-and-why-companies-enter-distribution-deals-researchandmarkets-c/ 2022-12-08T18:12:11+00:00 https://medicaex.com/businesswire/global-pharma-biotech-diagnostics-co-promotion-and-co-marketing-partnering-terms-and-agreements-analysis-report-2022-researchandmarkets-com-2/ 2022-12-08T18:12:10+00:00 https://medicaex.com/businesswire/global-coronavirus-partnering-deals-analysis-report-2022-gain-access-to-headline-upfront-milestone-and-royalty-data-researchandmarkets-com-2/ 2022-12-08T18:12:10+00:00 https://medicaex.com/businesswire/sonde-health-raises-19-25-million-series-b-to-build-the-next-generation-of-voice-based-health-monitoring-3/ 2022-12-08T18:12:08+00:00 https://medicaex.com/businesswire/infectious-disease-diagnostics-global-market-report-2022-availability-of-multiple-diagnostic-tests-boosts-growth-researchandmarkets-com-3/ 2022-12-08T18:12:07+00:00 https://medicaex.com/businesswire/sonde-health-raises-19-25-million-series-b-to-build-the-next-generation-of-voice-based-health-monitoring-2/ 2022-12-08T18:12:07+00:00 https://medicaex.com/businesswire/infectious-disease-diagnostics-global-market-report-2022-availability-of-multiple-diagnostic-tests-boosts-growth-researchandmarkets-com-2/ 2022-12-08T18:12:06+00:00 https://medicaex.com/businesswire/c2n-diagnostics-precivityad-and-precivityad2-blood-tests-at-ctad-2022-highlight-the-potential-and-use-of-blood-based-biomarkers-in-the-diagnosis-of-alzheimers-disease/ 2022-12-08T18:12:05+00:00 https://medicaex.com/businesswire/global-pharma-biotech-diagnostics-co-promotion-and-co-marketing-partnering-terms-and-agreements-analysis-report-2022-researchandmarkets-com/ 2022-12-08T18:12:05+00:00 https://medicaex.com/businesswire/global-coronavirus-partnering-deals-analysis-report-2022-gain-access-to-headline-upfront-milestone-and-royalty-data-researchandmarkets-com/ 2022-12-08T18:12:05+00:00 https://medicaex.com/businesswire/house-dust-mite-allergy-treatment-global-market-report-2022-an-alarming-surge-in-allergies-worldwide-drives-growth-researchandmarkets-com/ 2022-12-08T18:12:05+00:00 https://medicaex.com/businesswire/infectious-disease-diagnostics-global-market-report-2022-availability-of-multiple-diagnostic-tests-boosts-growth-researchandmarkets-com/ 2022-12-08T18:12:04+00:00 https://medicaex.com/businesswire/sonde-health-raises-19-25-million-series-b-to-build-the-next-generation-of-voice-based-health-monitoring/ 2022-12-08T18:12:03+00:00 https://medicaex.com/businesswire/immunohistochemistry-global-market-report-2022-rising-research-and-development-activities-for-the-development-of-innovative-products-drives-growth-researchandmarkets-com-4/ 2022-12-08T17:12:09+00:00 https://medicaex.com/businesswire/eigen-therapeutics-emerges-from-stealth-with-7m-in-funding-to-develop-therapies-that-address-cancer-heterogeneity-3/ 2022-12-08T17:12:09+00:00 https://medicaex.com/businesswire/eigen-therapeutics-emerges-from-stealth-with-7m-in-funding-to-develop-therapies-that-address-cancer-heterogeneity-2/ 2022-12-08T17:12:07+00:00 https://medicaex.com/businesswire/transdermal-skin-patches-market-2022-2028-featuring-interna-technologies-novartis-alembic-pfizer-more-researchandmarkets-com-2/ 2022-12-08T17:12:06+00:00 https://medicaex.com/businesswire/immunohistochemistry-global-market-report-2022-rising-research-and-development-activities-for-the-development-of-innovative-products-drives-growth-researchandmarkets-com-2/ 2022-12-08T17:12:06+00:00 https://medicaex.com/businesswire/immunohistochemistry-global-market-report-2022-rising-research-and-development-activities-for-the-development-of-innovative-products-drives-growth-researchandmarkets-com-3/ 2022-12-08T17:12:06+00:00 https://medicaex.com/businesswire/medidata-receives-prestigious-innovation-award-from-reagan-udall-foundation-for-the-fda/ 2022-12-08T17:12:05+00:00 https://medicaex.com/businesswire/immunohistochemistry-global-market-report-2022-rising-research-and-development-activities-for-the-development-of-innovative-products-drives-growth-researchandmarkets-com/ 2022-12-08T17:12:05+00:00 https://medicaex.com/businesswire/eigen-therapeutics-emerges-from-stealth-with-7m-in-funding-to-develop-therapies-that-address-cancer-heterogeneity/ 2022-12-08T17:12:05+00:00 https://medicaex.com/businesswire/transdermal-skin-patches-market-2022-2028-featuring-interna-technologies-novartis-alembic-pfizer-more-researchandmarkets-com/ 2022-12-08T17:12:04+00:00 https://medicaex.com/businesswire/pfizer-and-biontech-receive-u-s-fda-emergency-use-authorization-for-omicron-ba-4-ba-5-adapted-bivalent-covid-19-vaccine-in-children-under-5-years-2/ 2022-12-08T16:12:09+00:00 https://medicaex.com/businesswire/pta-balloon-catheter-market-report-2022-increasing-prevalence-of-cardiovascular-disease-drives-growth-researchandmarkets-com/ 2022-12-08T16:12:07+00:00 https://medicaex.com/businesswire/atricure-wins-2022-nacd-diversity-equity-inclusion-award/ 2022-12-08T16:12:07+00:00 https://medicaex.com/businesswire/arizona-experiencing-increase-in-illicit-fentanyl-exposure/ 2022-12-08T16:12:05+00:00 https://medicaex.com/businesswire/pfizer-and-biontech-receive-u-s-fda-emergency-use-authorization-for-omicron-ba-4-ba-5-adapted-bivalent-covid-19-vaccine-in-children-under-5-years/ 2022-12-08T16:12:05+00:00 https://medicaex.com/businesswire/ataxin-3-drugs-in-development-by-therapy-areas-and-indications-stages-moa-roa-molecule-type-and-key-players-researchandmarkets-com/ 2022-12-08T16:12:05+00:00 https://medicaex.com/businesswire/mometasone-furoate-global-market-report-2022-increasing-worldwide-prevalence-of-asthma-fueling-growth-researchandmarkets-com/ 2022-12-08T16:12:05+00:00 https://medicaex.com/businesswire/cancer-immunotherapy-global-market-report-2022-technological-advancements-and-introduction-of-novel-drugs-bolster-growth-researchandmarkets-com/ 2022-12-08T16:12:05+00:00 https://medicaex.com/businesswire/growth-opportunities-in-synthetic-biology-enablers-and-applications-microbiome-therapeutics-exosome-based-drug-delivery-researchandmarkets-com-2/ 2022-12-08T15:12:10+00:00 https://medicaex.com/businesswire/hospital-iq-named-to-the-2022-cb-insights-digital-health-150-list-2/ 2022-12-08T15:12:10+00:00 https://medicaex.com/businesswire/alsana-appoints-dr-nicole-garber-as-chief-medical-officer/ 2022-12-08T15:12:09+00:00 https://medicaex.com/businesswire/as-wallet-pressures-mount-women-look-to-science-backed-workouts-focused-on-health-and-wellness-according-to-national-fitness-leader-p-volve/ 2022-12-08T15:12:09+00:00 https://medicaex.com/businesswire/new-study-of-700-patients-finds-addressing-food-insecurity-can-reduce-healthcare-utilization-by-30/ 2022-12-08T15:12:09+00:00 https://medicaex.com/businesswire/azalea-health-appoints-chief-technology-officer/ 2022-12-08T15:12:08+00:00 https://medicaex.com/businesswire/dana-farber-cancer-institute-selects-vibrent-healths-next-generation-digital-health-research-platform-to-enable-early-detection-for-the-prevention-of-multiple-myeloma-2/ 2022-12-08T15:12:08+00:00 https://medicaex.com/businesswire/hospital-iq-named-to-the-2022-cb-insights-digital-health-150-list/ 2022-12-08T15:12:08+00:00 https://medicaex.com/businesswire/growth-opportunities-in-synthetic-biology-enablers-and-applications-microbiome-therapeutics-exosome-based-drug-delivery-researchandmarkets-com/ 2022-12-08T15:12:05+00:00 https://medicaex.com/businesswire/dana-farber-cancer-institute-selects-vibrent-healths-next-generation-digital-health-research-platform-to-enable-early-detection-for-the-prevention-of-multiple-myeloma/ 2022-12-08T15:12:04+00:00 https://medicaex.com/businesswire/omada-health-is-the-first-virtual-care-company-to-join-the-institute-for-healthcare-improvement-leadership-alliance/ 2022-12-08T15:12:04+00:00 https://medicaex.com/businesswire/bertis-announces-research-results-of-ai-based-disease-diagnosis-model-in-the-worlds-largest-academic-event-in-proteomics/ 2022-12-08T14:12:09+00:00 https://medicaex.com/businesswire/unibloc-hygienic-technologies-expands-capacity-with-cnc-machining-investment-in-uk/ 2022-12-08T14:12:09+00:00 https://medicaex.com/businesswire/agendia-level-1b-evidence-shows-mammaprint-is-the-first-and-only-fda-cleared-gene-expression-profiling-test-to-predict-benefit-from-extended-endocrine-therapy-in-early-stage-breast-cancer-patien-4/ 2022-12-08T14:12:09+00:00 https://medicaex.com/businesswire/evolus-extends-term-of-credit-facility-with-pharmakon-advisors-2/ 2022-12-08T14:12:09+00:00 https://medicaex.com/businesswire/nrdl-inclusion-offers-substantial-opportunities-for-innovative-clinically-differentiated-therapies-in-china-despite-steep-price-reductions-2/ 2022-12-08T14:12:09+00:00 https://medicaex.com/businesswire/blue-apron-provides-business-updates-and-outlines-plans-for-cost-reductions-and-liquidity-management/ 2022-12-08T14:12:08+00:00 https://medicaex.com/businesswire/vida-healths-spanish-language-virtual-diabetes-solution-achieves-meaningful-clinical-outcomes-3/ 2022-12-08T14:12:08+00:00 https://medicaex.com/businesswire/agendia-level-1b-evidence-shows-mammaprint-is-the-first-and-only-fda-cleared-gene-expression-profiling-test-to-predict-benefit-from-extended-endocrine-therapy-in-early-stage-breast-cancer-patien-3/ 2022-12-08T14:12:07+00:00 https://medicaex.com/businesswire/vida-healths-spanish-language-virtual-diabetes-solution-achieves-meaningful-clinical-outcomes-2/ 2022-12-08T14:12:07+00:00 https://medicaex.com/businesswire/planet-dds-partners-with-overjet-to-usher-in-new-era-of-ai-powered-dental-imaging-2/ 2022-12-08T14:12:07+00:00 https://medicaex.com/businesswire/oscar-health-survey-details-connection-between-economic-and-health-security-with-more-individuals-reassessing-their-health-insurance-and-prioritizing-their-healthcare-needs/ 2022-12-08T14:12:07+00:00 https://medicaex.com/businesswire/elara-caring-and-servicenow-drive-tech-innovations-in-home-health/ 2022-12-08T14:12:07+00:00 https://medicaex.com/businesswire/planet-dds-partners-with-overjet-to-usher-in-new-era-of-ai-powered-dental-imaging/ 2022-12-08T14:12:06+00:00 https://medicaex.com/businesswire/agendia-level-1b-evidence-shows-mammaprint-is-the-first-and-only-fda-cleared-gene-expression-profiling-test-to-predict-benefit-from-extended-endocrine-therapy-in-early-stage-breast-cancer-patien-2/ 2022-12-08T14:12:06+00:00 https://medicaex.com/businesswire/dexcom-g7-receives-fda-clearance-the-most-accurate-continuous-glucose-monitoring-system-cleared-in-the-u-s/ 2022-12-08T14:12:06+00:00 https://medicaex.com/businesswire/lucid-diagnostics-selected-as-finalist-for-medtech-company-of-the-year-2022-by-medical-device-diagnostic-industry/ 2022-12-08T14:12:06+00:00 https://medicaex.com/businesswire/nrdl-inclusion-offers-substantial-opportunities-for-innovative-clinically-differentiated-therapies-in-china-despite-steep-price-reductions/ 2022-12-08T14:12:05+00:00 https://medicaex.com/businesswire/camizestrant-significantly-delayed-disease-progression-in-advanced-er-positive-breast-cancer-adding-at-least-3-5-months-benefit-versus-faslodex-fulvestrant/ 2022-12-08T14:12:05+00:00 https://medicaex.com/businesswire/capivasertib-plus-faslodex-fulvestrant-reduced-the-risk-of-disease-progression-or-death-by-40-versus-faslodex-in-advanced-hr-positive-breast-cancer/ 2022-12-08T14:12:05+00:00 https://medicaex.com/businesswire/agendia-level-1b-evidence-shows-mammaprint-is-the-first-and-only-fda-cleared-gene-expression-profiling-test-to-predict-benefit-from-extended-endocrine-therapy-in-early-stage-breast-cancer-patien/ 2022-12-08T14:12:05+00:00 https://medicaex.com/businesswire/fresenius-kabi-introduces-pralatrexate-injection-for-the-treatment-of-relapsed-or-refractory-peripheral-t-cell-lymphoma/ 2022-12-08T14:12:04+00:00 https://medicaex.com/businesswire/evolus-extends-term-of-credit-facility-with-pharmakon-advisors/ 2022-12-08T14:12:04+00:00 https://medicaex.com/businesswire/health-benefit-cost-rose-3-2-in-2022-but-employers-see-bigger-increases-ahead-mercer-survey/ 2022-12-08T14:12:03+00:00 https://medicaex.com/businesswire/vida-healths-spanish-language-virtual-diabetes-solution-achieves-meaningful-clinical-outcomes/ 2022-12-08T14:12:03+00:00 https://medicaex.com/businesswire/vbi-vaccines-announces-health-canada-approval-for-prehevbrio-for-the-prevention-of-hepatitis-b-in-adults-2/ 2022-12-08T13:12:08+00:00 https://medicaex.com/businesswire/ipas-subsidiary-biostrand-completes-integration-of-20-million-proprietary-structural-hyfts-and-accelerates-in-silico-drug-discovery-developments-2/ 2022-12-08T13:12:08+00:00 https://medicaex.com/businesswire/exelixis-announces-initial-dose-escalation-results-from-the-first-in-human-phase-1-trial-evaluating-xl102-in-patients-with-advanced-solid-tumors-at-sabcs-2022-2/ 2022-12-08T13:12:08+00:00 https://medicaex.com/businesswire/scorpion-therapeutics-presents-preclinical-data-for-potential-best-in-class-pi3k%ce%b1-inhibitor-at-san-antonio-breast-cancer-symposium-3/ 2022-12-08T13:12:08+00:00 https://medicaex.com/businesswire/ksq-appoints-mahesh-karande-to-its-board-of-directors-2/ 2022-12-08T13:12:08+00:00 https://medicaex.com/businesswire/scorpion-therapeutics-presents-preclinical-data-for-potential-best-in-class-pi3k%ce%b1-inhibitor-at-san-antonio-breast-cancer-symposium-2/ 2022-12-08T13:12:06+00:00 https://medicaex.com/businesswire/top-healthcare-executives-join-nuvoairs-board-of-directors-2/ 2022-12-08T13:12:06+00:00 https://medicaex.com/businesswire/quantum-si-joins-human-proteome-organization-hupo-industrial-advisory-board/ 2022-12-08T13:12:06+00:00 https://medicaex.com/businesswire/global-3d-cell-culture-market-report-2022-development-of-3d-cell-cultures-based-on-microfluidics-drives-growth-researchandmarkets-com/ 2022-12-08T13:12:06+00:00 https://medicaex.com/businesswire/flocculant-dosing-system-global-market-report-2022-rising-demand-for-chemicals-in-municipal-water-treatment-drives-growth-researchandmarkets-com/ 2022-12-08T13:12:05+00:00 https://medicaex.com/businesswire/ipas-subsidiary-biostrand-completes-integration-of-20-million-proprietary-structural-hyfts-and-accelerates-in-silico-drug-discovery-developments/ 2022-12-08T13:12:04+00:00 https://medicaex.com/businesswire/exelixis-announces-initial-dose-escalation-results-from-the-first-in-human-phase-1-trial-evaluating-xl102-in-patients-with-advanced-solid-tumors-at-sabcs-2022/ 2022-12-08T13:12:04+00:00 https://medicaex.com/businesswire/scorpion-therapeutics-presents-preclinical-data-for-potential-best-in-class-pi3k%ce%b1-inhibitor-at-san-antonio-breast-cancer-symposium/ 2022-12-08T13:12:04+00:00 https://medicaex.com/businesswire/ksq-appoints-mahesh-karande-to-its-board-of-directors/ 2022-12-08T13:12:04+00:00 https://medicaex.com/businesswire/vbi-vaccines-announces-health-canada-approval-for-prehevbrio-for-the-prevention-of-hepatitis-b-in-adults/ 2022-12-08T13:12:04+00:00 https://medicaex.com/businesswire/top-healthcare-executives-join-nuvoairs-board-of-directors/ 2022-12-08T13:12:03+00:00 https://medicaex.com/businesswire/pspnet-families-announces-launch-of-new-website-with-wellbeing-supports-for-family-members-of-public-safety-personnel-and-first-responders/ 2022-12-08T13:12:03+00:00 https://medicaex.com/businesswire/vertex-and-entrada-therapeutics-establish-collaboration-to-discover-and-develop-endosomal-escape-vehicle-eev-therapeutics-for-myotonic-dystrophy-type-1-dm1-2/ 2022-12-08T12:12:11+00:00 https://medicaex.com/businesswire/vizgen-launches-merscope-formalin-fixed-paraffin-embedded-ffpe-solution-kit/ 2022-12-08T12:12:11+00:00 https://medicaex.com/businesswire/major-healthcare-companies-trade-associations-and-non-profits-turn-to-fiscalnote-for-policy-monitoring-actionable-solutions-and-risk-mitigation-2/ 2022-12-08T12:12:11+00:00 https://medicaex.com/businesswire/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit-2/ 2022-12-08T12:12:11+00:00 https://medicaex.com/businesswire/alnylam-to-webcast-virtual-rd-day-2/ 2022-12-08T12:12:11+00:00 https://medicaex.com/businesswire/better-therapeutics-completes-exploratory-trial-for-fatty-liver-disease-and-announces-positive-topline-results/ 2022-12-08T12:12:09+00:00 https://medicaex.com/businesswire/grow-therapy-announces-multi-state-expansion-increasing-americans-access-to-quality-mental-health-care-2/ 2022-12-08T12:12:09+00:00 https://medicaex.com/businesswire/walgreens-launches-free-paxlovid-delivery-services-with-doordash-and-uber/ 2022-12-08T12:12:06+00:00 https://medicaex.com/businesswire/vertex-and-entrada-therapeutics-establish-collaboration-to-discover-and-develop-endosomal-escape-vehicle-eev-therapeutics-for-myotonic-dystrophy-type-1-dm1/ 2022-12-08T12:12:05+00:00 https://medicaex.com/businesswire/major-healthcare-companies-trade-associations-and-non-profits-turn-to-fiscalnote-for-policy-monitoring-actionable-solutions-and-risk-mitigation/ 2022-12-08T12:12:05+00:00 https://medicaex.com/businesswire/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit/ 2022-12-08T12:12:05+00:00 https://medicaex.com/businesswire/can-fites-partner-vetbiolix-is-heading-into-a-european-multicentric-clinical-trial-with-piclidenoson-for-the-treatment-of-pets-osteoarthritis/ 2022-12-08T12:12:05+00:00 https://medicaex.com/businesswire/alnylam-to-webcast-virtual-rd-day/ 2022-12-08T12:12:05+00:00 https://medicaex.com/businesswire/grow-therapy-announces-multi-state-expansion-increasing-americans-access-to-quality-mental-health-care/ 2022-12-08T12:12:04+00:00 https://medicaex.com/businesswire/united-therapeutics-named-by-newsweek-as-one-of-americas-most-responsible-companies-2023-2/ 2022-12-08T11:12:10+00:00 https://medicaex.com/businesswire/20000-increase-for-employers-youth-mental-health-telehealth-costs-soar-amid-double-digit-jumps-in-diagnoses-suicide-attempts-3/ 2022-12-08T11:12:10+00:00 https://medicaex.com/businesswire/mtti-obtains-fda-allowance-of-investigational-new-drug-ind-for-hurthle-cell-thyroid-cancer-2/ 2022-12-08T11:12:10+00:00 https://medicaex.com/businesswire/ophthalmic-diagnostics-equipment-global-market-2022-focused-rd-for-novel-devices-fuels-growth-researchandmarkets-com/ 2022-12-08T11:12:08+00:00 https://medicaex.com/businesswire/united-states-medical-equipment-supplies-market-2022-researchandmarkets-com/ 2022-12-08T11:12:07+00:00 https://medicaex.com/businesswire/continuous-renal-replacement-therapy-global-market-report-2022-demand-from-emerging-markets-such-as-china-india-and-brazil-presents-opportunities-researchandmarkets-com/ 2022-12-08T11:12:07+00:00 https://medicaex.com/businesswire/20000-increase-for-employers-youth-mental-health-telehealth-costs-soar-amid-double-digit-jumps-in-diagnoses-suicide-attempts-2/ 2022-12-08T11:12:06+00:00 https://medicaex.com/businesswire/mtti-obtains-fda-allowance-of-investigational-new-drug-ind-for-hurthle-cell-thyroid-cancer/ 2022-12-08T11:12:05+00:00 https://medicaex.com/businesswire/united-therapeutics-named-by-newsweek-as-one-of-americas-most-responsible-companies-2023/ 2022-12-08T11:12:05+00:00 https://medicaex.com/businesswire/20000-increase-for-employers-youth-mental-health-telehealth-costs-soar-amid-double-digit-jumps-in-diagnoses-suicide-attempts/ 2022-12-08T11:12:04+00:00 https://medicaex.com/businesswire/the-native-antigen-company-expands-infectious-disease-portfolio-to-include-sudan-ebolavirus-boniface-1976-glycoprotein-3/ 2022-12-08T10:12:07+00:00 https://medicaex.com/businesswire/the-native-antigen-company-expands-infectious-disease-portfolio-to-include-sudan-ebolavirus-boniface-1976-glycoprotein-2/ 2022-12-08T10:12:05+00:00 https://medicaex.com/businesswire/the-native-antigen-company-expands-infectious-disease-portfolio-to-include-sudan-ebolavirus-boniface-1976-glycoprotein/ 2022-12-08T10:12:03+00:00 https://medicaex.com/businesswire/crown-bioscience-and-ers-genomics-announce-global-crispr-cas9-licensing-agreement-for-genome-editing-patents-2/ 2022-12-08T09:12:28+00:00 https://medicaex.com/businesswire/crown-bioscience-and-ers-genomics-announce-global-crispr-cas9-licensing-agreement-for-genome-editing-patents/ 2022-12-08T09:12:24+00:00 https://medicaex.com/businesswire/primary-endpoint-met-in-the-clear-outcomes-trial-of-bempedoic-acid-showing-statistically-significant-relative-risk-reduction-in-major-adverse-cv-events-2/ 2022-12-08T07:12:08+00:00 https://medicaex.com/businesswire/novadip-biosciences-sa-announces-positive-results-from-phase-1-2-clinical-trial-in-patients-with-severe-bone-non-union-of-the-lower-limb-following-trauma-2/ 2022-12-08T07:12:08+00:00 https://medicaex.com/businesswire/onward-reports-interim-clinical-outcomes-for-implantable-arc-therapy-demonstrating-potential-to-improve-blood-pressure-regulation-after-spinal-cord-injury/ 2022-12-08T07:12:04+00:00 https://medicaex.com/businesswire/primary-endpoint-met-in-the-clear-outcomes-trial-of-bempedoic-acid-showing-statistically-significant-relative-risk-reduction-in-major-adverse-cv-events/ 2022-12-08T07:12:04+00:00 https://medicaex.com/businesswire/novadip-biosciences-sa-announces-positive-results-from-phase-1-2-clinical-trial-in-patients-with-severe-bone-non-union-of-the-lower-limb-following-trauma/ 2022-12-08T07:12:04+00:00 https://medicaex.com/businesswire/puma-biotechnology-presents-updated-findings-from-the-tbcrc-022-trial-at-the-2022-san-antonio-breast-cancer-symposium-2/ 2022-12-07T23:12:08+00:00 https://medicaex.com/businesswire/puma-biotechnology-presents-updated-findings-from-the-tbcrc-022-trial-at-the-2022-san-antonio-breast-cancer-symposium/ 2022-12-07T23:12:05+00:00 https://medicaex.com/businesswire/kite-and-daiichi-sankyo-announce-changes-to-yescarta-car-t-cell-therapy-licensing-agreement-in-japan-2/ 2022-12-07T22:12:08+00:00 https://medicaex.com/businesswire/johnson-johnson-to-participate-in-the-41st-annual-j-p-morgan-healthcare-conference-4/ 2022-12-07T22:12:07+00:00 https://medicaex.com/businesswire/myomo-provides-update-on-progress-to-obtain-medicare-part-b-reimbursement-for-myopro/ 2022-12-07T22:12:06+00:00 https://medicaex.com/businesswire/johnson-johnson-to-participate-in-the-41st-annual-j-p-morgan-healthcare-conference-3/ 2022-12-07T22:12:06+00:00 https://medicaex.com/businesswire/johnson-johnson-to-participate-in-the-41st-annual-j-p-morgan-healthcare-conference-2/ 2022-12-07T22:12:05+00:00 https://medicaex.com/businesswire/johnson-johnson-to-participate-in-the-41st-annual-j-p-morgan-healthcare-conference/ 2022-12-07T22:12:04+00:00 https://medicaex.com/businesswire/kite-and-daiichi-sankyo-announce-changes-to-yescarta-car-t-cell-therapy-licensing-agreement-in-japan/ 2022-12-07T22:12:04+00:00 https://medicaex.com/businesswire/imv-shareholders-approve-reverse-stock-split-at-88-2/ 2022-12-07T21:12:08+00:00 https://medicaex.com/businesswire/kezar-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2/ 2022-12-07T21:12:08+00:00 https://medicaex.com/businesswire/cutera-inc-announces-proposed-private-offering-of-100-million-of-convertible-senior-notes/ 2022-12-07T21:12:06+00:00 https://medicaex.com/businesswire/imv-shareholders-approve-reverse-stock-split-at-88/ 2022-12-07T21:12:05+00:00 https://medicaex.com/businesswire/kezar-announces-inducement-grants-under-nasdaq-listing-rule-5635c4/ 2022-12-07T21:12:05+00:00 https://medicaex.com/businesswire/spinethera-announces-results-for-sx600-from-its-salient-phase-2-sciatica-pain-clinical-trial-supporting-the-potential-for-best-in-class-therapy-2/ 2022-12-07T20:12:10+00:00 https://medicaex.com/businesswire/spinethera-announces-results-for-sx600-from-its-salient-phase-2-sciatica-pain-clinical-trial-supporting-the-potential-for-best-in-class-therapy/ 2022-12-07T20:12:06+00:00 https://medicaex.com/businesswire/agilent-again-named-to-newsweeks-list-of-americas-most-responsible-companies-2/ 2022-12-07T19:12:09+00:00 https://medicaex.com/businesswire/the-herbalife-nutrition-foundation-partners-with-global-foodbanking-network-to-remind-the-public-how-they-can-help-reduce-hunger/ 2022-12-07T19:12:08+00:00 https://medicaex.com/businesswire/hyfe-listed-on-2022-cb-insights-digital-health-150-list-recognizing-the-most-promising-digital-health-companies/ 2022-12-07T19:12:07+00:00 https://medicaex.com/businesswire/outlook-on-the-x-ray-device-global-market-to-2032-by-portability-application-portability-type-technology-product-type-and-region-researchandmarkets-com/ 2022-12-07T19:12:06+00:00 https://medicaex.com/businesswire/agilent-again-named-to-newsweeks-list-of-americas-most-responsible-companies/ 2022-12-07T19:12:05+00:00 https://medicaex.com/businesswire/middle-east-africa-fitness-equipment-market-report-to-2027-featuring-icon-health-fitness-life-fitness-johnson-health-tech-and-technogym-among-others-researchandmarkets-com/ 2022-12-07T18:12:08+00:00 https://medicaex.com/businesswire/tevogen-bio-to-study-its-investigational-covid-19-t-cell-therapy-in-immunocompromised-patients-who-are-unable-to-benefit-from-currently-available-prevention-or-treatment-options-2/ 2022-12-07T18:12:08+00:00 https://medicaex.com/businesswire/generate-biomedicines-demonstrates-a-novel-method-of-reducing-immunogenicity-through-protein-re-surfacing-2/ 2022-12-07T18:12:08+00:00 https://medicaex.com/businesswire/global-hemodialysis-market-report-2022-to-2030-increasing-number-of-esrd-patients-is-driving-growth-researchandmarkets-com-3/ 2022-12-07T18:12:08+00:00 https://medicaex.com/businesswire/wwes-next-in-line-program-partners-with-exos/ 2022-12-07T18:12:07+00:00 https://medicaex.com/businesswire/foot-and-ankle-devices-market-report-2022-featuring-stryker-zimmer-biomet-smith-nephew-arthrex-integra-lifesciences-researchandmarkets-com/ 2022-12-07T18:12:06+00:00 https://medicaex.com/businesswire/global-hemodialysis-market-report-2022-to-2030-increasing-number-of-esrd-patients-is-driving-growth-researchandmarkets-com-2/ 2022-12-07T18:12:06+00:00 https://medicaex.com/businesswire/prime-health-services-announces-acquisition-of-intergroup-services-provider-network/ 2022-12-07T18:12:05+00:00 https://medicaex.com/businesswire/global-hemodialysis-market-report-2022-to-2030-increasing-number-of-esrd-patients-is-driving-growth-researchandmarkets-com/ 2022-12-07T18:12:05+00:00 https://medicaex.com/businesswire/tevogen-bio-to-study-its-investigational-covid-19-t-cell-therapy-in-immunocompromised-patients-who-are-unable-to-benefit-from-currently-available-prevention-or-treatment-options/ 2022-12-07T18:12:04+00:00 https://medicaex.com/businesswire/2022-world-market-for-vaccines-the-market-is-valued-at-202-6-billion-up-from-34-1-billion-in-2017-researchandmarkets-com/ 2022-12-07T18:12:04+00:00 https://medicaex.com/businesswire/generate-biomedicines-demonstrates-a-novel-method-of-reducing-immunogenicity-through-protein-re-surfacing/ 2022-12-07T18:12:04+00:00 https://medicaex.com/businesswire/global-microbiome-therapeutics-market-report-2022-featuring-10x-genomics-4d-molecular-therapeutics-abb-and-abbvie-among-others-researchandmarkets-com/ 2022-12-07T17:12:10+00:00 https://medicaex.com/businesswire/cell-culture-global-market-report-2022-advancements-in-3d-culture-technologies-driving-sector-researchandmarkets-com-2/ 2022-12-07T17:12:10+00:00 https://medicaex.com/businesswire/healthcare-bpo-market-2022-2028-upcoming-increases-in-healthcare-expenditure-across-key-markets-to-fuel-growth-researchandmarkets-com-3/ 2022-12-07T17:12:09+00:00 https://medicaex.com/businesswire/global-smart-speaker-market-research-report-2022-to-2028-featuring-anker-technology-apple-baidu-and-logitech-among-others-researchandmarkets-com-2/ 2022-12-07T17:12:09+00:00 https://medicaex.com/businesswire/worldwide-large-molecule-bioanalytical-testing-services-industry-to-2029-increased-complication-of-product-designs-and-engineering-is-driving-growth-researchandmarkets-com-2/ 2022-12-07T17:12:09+00:00 https://medicaex.com/businesswire/healthcare-bpo-market-2022-2028-upcoming-increases-in-healthcare-expenditure-across-key-markets-to-fuel-growth-researchandmarkets-com-2/ 2022-12-07T17:12:08+00:00 https://medicaex.com/businesswire/the-worldwide-ngs-kits-industry-is-expected-to-reach-26-billion-by-2032-exponential-rise-in-next-generation-sequencing-ngs-demand-due-to-reducing-cost-of-genome-sequencing-researchandmarkets-com-3/ 2022-12-07T17:12:06+00:00 https://medicaex.com/businesswire/the-worldwide-ngs-kits-industry-is-expected-to-reach-26-billion-by-2032-exponential-rise-in-next-generation-sequencing-ngs-demand-due-to-reducing-cost-of-genome-sequencing-researchandmarkets-com-2/ 2022-12-07T17:12:05+00:00 https://medicaex.com/businesswire/healthcare-bpo-market-2022-2028-upcoming-increases-in-healthcare-expenditure-across-key-markets-to-fuel-growth-researchandmarkets-com/ 2022-12-07T17:12:04+00:00 https://medicaex.com/businesswire/global-smart-speaker-market-research-report-2022-to-2028-featuring-anker-technology-apple-baidu-and-logitech-among-others-researchandmarkets-com/ 2022-12-07T17:12:04+00:00 https://medicaex.com/businesswire/worldwide-large-molecule-bioanalytical-testing-services-industry-to-2029-increased-complication-of-product-designs-and-engineering-is-driving-growth-researchandmarkets-com/ 2022-12-07T17:12:04+00:00 https://medicaex.com/businesswire/cell-culture-global-market-report-2022-advancements-in-3d-culture-technologies-driving-sector-researchandmarkets-com/ 2022-12-07T17:12:04+00:00 https://medicaex.com/businesswire/the-worldwide-ngs-kits-industry-is-expected-to-reach-26-billion-by-2032-exponential-rise-in-next-generation-sequencing-ngs-demand-due-to-reducing-cost-of-genome-sequencing-researchandmarkets-com/ 2022-12-07T17:12:04+00:00 https://medicaex.com/businesswire/imidomics-announces-appointment-of-key-science-and-medical-research-experts-to-newly-formed-immunology-advisory-board-2/ 2022-12-07T16:12:09+00:00 https://medicaex.com/businesswire/synthetic-small-molecule-api-market-report-2022-increased-outsourcing-of-api-production-drives-growth-researchandmarkets-com-2/ 2022-12-07T16:12:09+00:00 https://medicaex.com/businesswire/rnai-technology-global-market-report-2022-rising-focus-on-rnai-therapy-development-drives-growth-researchandmarkets-com/ 2022-12-07T16:12:09+00:00 https://medicaex.com/businesswire/global-laboratory-informatics-market-report-2022-to-2032-decreasing-cost-due-to-increasing-use-of-cloud-based-systems-presents-opportunities-researchandmarkets-com/ 2022-12-07T16:12:07+00:00 https://medicaex.com/businesswire/global-specialty-medical-chairs-market-report-2022-to-2030-a-growing-geriatric-population-and-increasing-reimbursement-policies-are-driving-growth-researchandmarkets-com-2/ 2022-12-07T16:12:07+00:00 https://medicaex.com/businesswire/global-specialty-medical-chairs-market-report-2022-to-2030-a-growing-geriatric-population-and-increasing-reimbursement-policies-are-driving-growth-researchandmarkets-com/ 2022-12-07T16:12:06+00:00 https://medicaex.com/businesswire/imidomics-announces-appointment-of-key-science-and-medical-research-experts-to-newly-formed-immunology-advisory-board/ 2022-12-07T16:12:05+00:00 https://medicaex.com/businesswire/synthetic-small-molecule-api-market-report-2022-increased-outsourcing-of-api-production-drives-growth-researchandmarkets-com/ 2022-12-07T16:12:05+00:00 https://medicaex.com/businesswire/verasonics-expands-leadership-announcing-additions-to-the-executive-team-and-new-focus-in-commercial-sales-2/ 2022-12-07T15:12:11+00:00 https://medicaex.com/businesswire/aarvik-therapeutics-announces-a-global-novel-payload-agreement-with-nj-bio-inc-2/ 2022-12-07T15:12:11+00:00 https://medicaex.com/businesswire/cenobamate-ontozry-for-the-treatment-of-uncontrolled-focal-onset-seizures-in-adults-is-now-available-in-france-and-belgium-2/ 2022-12-07T15:12:11+00:00 https://medicaex.com/businesswire/oxford-nanopore-technology-update-shows-consolidations-and-updates-for-a-single-high-performance-sequencing-platform/ 2022-12-07T15:12:11+00:00 https://medicaex.com/businesswire/microbiome-sample-preparation-technology-market-report-2022-rising-rd-investments-by-lead-players-fuels-sector-researchandmarkets-com/ 2022-12-07T15:12:11+00:00 https://medicaex.com/businesswire/oral-health-organizations-urge-congress-to-strengthen-extensive-adult-dental-benefits-for-all-state-medicaid-programs-4/ 2022-12-07T15:12:09+00:00 https://medicaex.com/businesswire/alkaline88-strengthens-its-position-in-golds-gyms/ 2022-12-07T15:12:09+00:00 https://medicaex.com/businesswire/webmd-provider-services-partners-with-patient-communications-leader-artera-to-improve-access-and-engagement-for-patient-education-and-medication-affordability-programs-2/ 2022-12-07T15:12:08+00:00